
eureKING — Investor Relations & Filings
eureKING is a Special Purpose Acquisition Company (SPAC) focused on the European healthcare sector, with a specific dedication to biomanufacturing. Founded in March 2022, the company's primary objective is to acquire and combine with European companies specializing in the production and manufacture of biopharmaceuticals. Through these strategic acquisitions, eureKING aims to build a leading European bio-CDMO (Contract Development and Manufacturing Organization). Its investment focus covers all stages of the biomanufacturing process, from clinical development through to commercialization and the full product lifecycle.
Recent filings
Browse filings by year
3 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Moberg Pharma
Pharmaceutical company developing and commercializing treat…
|
MOB | SE | Manufacturing |
|
Mochida Pharmaceutical Co.,Ltd.
Develops and sells pharmaceuticals, healthcare products, an…
|
4534 | JP | Manufacturing |
|
Modalis Therapeutics Corporation
Develops genetic medicines using a proprietary epigenome ed…
|
4883 | JP | Manufacturing |
|
Moderna, Inc.
Biotechnology company developing messenger RNA (mRNA) thera…
|
MRNA | US | Manufacturing |
|
Modern Chinese Medicine Group Co., Ltd.
Produces and sells proprietary modern Chinese medicines, sp…
|
1643 | HK | Manufacturing |
|
Molecular Partners AG
Clinical-stage company developing novel protein therapeutic…
|
MOLN | CH | Manufacturing |
|
Moleculin Biotech, Inc.
A late-stage pharmaceutical company developing drugs for re…
|
MBRX | US | Manufacturing |
|
Monte Rosa Therapeutics, Inc.
Develops molecular glue degraders to eliminate disease-caus…
|
GLUE | US | Manufacturing |
|
Moogene Medi Co., Ltd.
Develops nanomedicine-based drug delivery systems for treat…
|
322970 | KR | Manufacturing |
|
MoonLake Immunotherapeutics
Clinical-stage biopharma developing Nanobody therapies for …
|
MLTX | US | Manufacturing |
eureKING via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/1303/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=1303 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=1303 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=1303 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 1303}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for eureKING (id: 1303)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.